Clinical Trial Update: Naproxen Sodium ER Pharmacokinetic Study [Phase 1]

View source ↗

Summary

The Bayer-sponsored Phase 1 pharmacokinetic study of Naproxen Sodium ER has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Naproxen Sodium ER (naproxen sodium)

Snippet

Sponsor: Bayer | Conditions: Pain | Phase 1 | Status: COMPLETED